Biotechnology's Role In Combating Antibiotic Resistance And Safeguarding Public Health
DOI:
https://doi.org/10.53555/jaz.v44i5.3159Keywords:
Antibiotic resistance, Biotechnology, Phage therapy, CRISPR-Cas, Synthetic biology, Diagnostics, Probiotics, Microbiome modulation, Public healthAbstract
Antibiotic resistance poses a significant threat to public health, rendering once-effective antibiotics ineffective against bacterial infections. The rise of multidrug-resistant pathogens necessitates innovative approaches to combat this global crisis. Biotechnology, with its diverse tools and techniques, emerges as a crucial player in addressing antibiotic resistance. This research article explores the multifaceted role of biotechnology in combating antibiotic resistance and safeguarding public health
Downloads
References
Abedon, S. T. (2017). Phage therapy: Various perspectives on how to improve the art. Frontiers in Microbiology, 8, 180.
Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.
Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., ... & Venter, J. C. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 329(5987), 52-56.
Honda, K., & Littman, D. R. (2016). The microbiome in infectious disease and inflammation. Annual Review of Immunology, 30, 759-795.
Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J. H., Chinwalla, A. T., ... & White, O. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207-214.
Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012). A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Reports, 127(1), 4-22.
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F., Sumpradit, N., ... & Cars, O. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057-1098.
Lehtinen, M. J., Hibberd, A. A., Männikkö, S., Yeung, N., Kauko, T., Forssten, S., ... & Ouwehand, A. C. (2013). Probiotic intervention modulates the inflammatory response and improves clinical outcomes in experimental pneumococcal meningitis. BMC Infectious Diseases, 13(1), 1-14.
Piddock, L. J. (2012). The crisis of no new antibiotics—what is the way forward?. The Lancet Infectious Diseases, 12(3), 249-253.
Sommer, M. O., Munck, C., Toft-Kehler, R. V., & Andersson, D. I. (2017). Prediction of antibiotic resistance: time for a new preclinical paradigm?. Nature Reviews Microbiology, 15(11), 689-696.
Theuretzbacher, U., Piddock, L. J., Non-Committee, T., & Society, B. S. (2019). Resistance drives antibacterial drug discovery. Antibiotics, 8(4), 179.
World Health Organization. (2015). Global action plan on antimicrobial resistance. Retrieved from https://www.who.int/antimicrobial-resistance/global-action-plan/en/
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Prof. Dr. Pratik Rajan Mungekar

This work is licensed under a Creative Commons Attribution 4.0 International License.